SCHEMBL5689690

SCHEMBL5689690

O=C(CCc1ccccc1)NC(CO)CO

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC2 Q92769 1/20 0.59
▸ HDAC8 Q9BY41 1/20 0.59
▸ HDAC6 Q9UBN7 1/20 0.59
▸ HDAC1 Q13547 3/20 0.56
▸ MAPT P10636 2/20 0.56
▸ HTT P42858 1/20 0.56
▸ ALDH1A1 P00352 1/20 0.54
▸ KEAP1 Q14145 1/20 0.52
▸ GAA P10253 1/20 0.51
▸ PARP1 P09874 1/20 0.51
▸ PARP3 Q9Y6F1 1/20 0.51
▸ SMN1; SMN2 Q16637 2/20 0.50
▸ TSHR P16473 1/20 0.50
▸ HDAC3 O15379 1/20 0.50
▸ CNR2 P34972 1/20 0.50
▸ RAB9A P51151 2/20 0.49
▸ KDM4E B2RXH2 1/20 0.49
▸ RECQL P46063 1/20 0.49
▸ NPC1 O15118 1/20 0.49
▸ KMT2A Q03164 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2957806 0.92 PARP1 (0.60) HDAC2HDAC8HDAC6HDAC1MAPT
SCHEMBL26393844 0.90 SMN1; SMN2 (0.63) HDAC2HDAC8HDAC6HDAC1SMN1; SMN2
SCHEMBL2956584 0.85 PARP1 (0.55) HDAC2HDAC8HDAC6HDAC1ALDH1A1
SCHEMBL12009652 0.85 PARP1 (0.55) HDAC2HDAC8HDAC6HDAC1ALDH1A1
SCHEMBL12009650 0.85 PARP1 (0.55) HDAC2HDAC8HDAC6HDAC1ALDH1A1
SCHEMBL12009653 0.85 PARP1 (0.55) HDAC2HDAC8HDAC6HDAC1ALDH1A1
SCHEMBL2947474 0.85 PARP1 (0.55) HDAC2HDAC8HDAC6HDAC1ALDH1A1
SCHEMBL12714254 0.84 CYP3A4 (0.55) HDAC1GAAPARP1PARP3KMT2A
SCHEMBL6138237 0.83 HDAC2 (0.56) HDAC2HDAC8HDAC6HDAC1MAPT
SCHEMBL12009636 0.80 HPGD (0.68) HDAC2HDAC8HDAC6SMN1; SMN2HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0982026-B1 Use of aryl-cyclohexylamine derivatives in the manufacture of NMDA receptor blockers HOFFMANN LA ROCHE (CH) 2006-05-17 — — EP disclosed
CN-1141936-C Usage of aryl-cyclohexylamine derivant in anti-disturbance of central nervous system - 2004-03-17 — — CN disclosed
US-6184236-B1 Method of treating a neurodegenerative disease by administering an aryl-cyclohexylamine derivative HOFFMANN-LA ROCHE INC. 2001-02-06 — — US disclosed
CN-1248439-A Usage of aryl-cyclohexylamine derivant in anti-disturbance of central nervous system HOFFMAN LA ROCHE & CO AKTEINGE (DE) 2000-03-29 — — CN disclosed
EP-0982026-A2 Use of aryl-cyclohexylamine derivatives in the manufacture of NMDA receptor blockers F. HOFFMANN-LA ROCHE AG (CH) 2000-03-01 — — EP disclosed
Send feedback